arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

LivaNova PLC

LIVN
$76.19 ▲ +0.39 (+0.52%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
51 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
43
Health
Weak
Bearish
auto_awesome

Analytical Summary

LivaNova PLC faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.2B
Dividend Yield
Revenue Growth 14.3%
Op. Margin 11.4%
ROIC 2.2%
FCF / Share $0.02
Trailing P/E 185.8x
Price / Book 3.5x
FCF Yield 0.0%
Debt / Equity 0.24
info Valuation on last close. End-of-day price, Aug 7, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$362.26M
↑ +14.3%
Net Income Profit after all expenses
$22.29M
↓ -27.9%
Operating Margin Operating profit as % of sales
11.4%
↓ -3.0% 66th
FCF / Share Free cash flow per share
$0.02
↓ -93.0%
Long-Term Debt Long-term obligations
$285.28M
↓ -24.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
48
Returns
28
Financial Health
70
Cash Quality
12

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 51 quarters